Literature DB >> 15070096

In situ-forming pharmaceutical organogels based on the self-assembly of L-alanine derivatives.

Anne-Claude Couffin-Hoarau1, Aude Motulsky, Pascal Delmas, Jean-Christophe Leroux.   

Abstract

PURPOSE: To characterize novel pharmaceutical organogels based on the self-assembly of L-alanine derivatives in hydrophobic vehicles.
METHODS: The gelation properties of N-lauroyl-L-alanine (LA) and N-lauroyl-L-alanine methyl ester (LAM) were investigated in the presence of various solvents. Gel-sol and sol-gel transitions were evaluated by the inverse flow method, and gelation kinetics were determined by turbidimetry. The in vitro release kinetics of labeled dextran physically dispersed in the oil-based organogel was assessed in phosphate-buffered saline. In situ formation of the implants was evaluated in rats by subcutaneously injecting a solution containing LAM, an oil, and a water-diffusible inhibitor of self-assembly (ethanol).
RESULTS: The LAM-containing formulations showed a hysteretic gelling behavior with transition temperatures between 10 and 55 degrees C. Gelation kinetics exhibited a lag time of 10 and 30 min at 25 and 37 degrees C, respectively. In vitro, fluorescein isothiocyanate-dextran was released from the gel in a sustained manner with less than 6% released after 20 days. The addition of ethanol to the LAM/oil mixture inhibited gelation and allowed subcutaneous injection of the solution at room temperature. After injection, ethanol diffusion led to the formation of a solid implant.
CONCLUSIONS: Low-molecular weight self-assembling organogelators may allow the preparation of novel in situ-forming hydrophobic implants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070096     DOI: 10.1023/B:PHAM.0000019299.01265.05

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins.

Authors:  R E Eliaz; J Kost
Journal:  J Biomed Mater Res       Date:  2000-06-05

2.  Low Molecular Mass Gelators of Organic Liquids and the Properties of Their Gels.

Authors:  Pierre Terech; Richard G. Weiss
Journal:  Chem Rev       Date:  1997-12-18       Impact factor: 60.622

Review 3.  Biodegradable injectable in situ forming drug delivery systems.

Authors:  A Hatefi; B Amsden
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

4.  Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy.

Authors:  T Eldem; P Speiser; H Altorfer
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

Review 5.  Thermosensitive sol-gel reversible hydrogels.

Authors:  Byeongmoon Jeong; Sung Wan Kim; You Han Bae
Journal:  Adv Drug Deliv Rev       Date:  2002-01-17       Impact factor: 15.470

6.  In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs.

Authors:  J Cappello; J W Crissman; M Crissman; F A Ferrari; G Textor; O Wallis; J R Whitledge; X Zhou; D Burman; L Aukerman; E R Stedronsky
Journal:  J Control Release       Date:  1998-04-30       Impact factor: 9.776

7.  Water-in-sorbitan monostearate organogels (water-in-oil gels).

Authors:  S Murdan; B van den Bergh; G Gregoriadis; A T Florence
Journal:  J Pharm Sci       Date:  1999-06       Impact factor: 3.534

8.  Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice.

Authors:  T P Johnston; M A Punjabi; C J Froelich
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

9.  Lipid microparticles as a parenteral controlled release device for peptides.

Authors:  H Reithmeier; J Herrmann; A Göpferich
Journal:  J Control Release       Date:  2001-06-15       Impact factor: 9.776

10.  Characterization of thermosensitive chitosan gels for the sustained delivery of drugs.

Authors:  E Ruel-Gariépy; A Chenite; C Chaput; S Guirguis; J Leroux
Journal:  Int J Pharm       Date:  2000-08-10       Impact factor: 5.875

  10 in total
  9 in total

1.  Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease.

Authors:  Guillaume Bastiat; François Plourde; Aude Motulsky; Alexandra Furtos; Yvan Dumont; Rémi Quirion; Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Biomaterials       Date:  2010-05-15       Impact factor: 12.479

2.  Synthesis, Characterization and Biocompatibility of N-palmitoyl L-alanine-based Organogels as Sustained Implants of Granisetron and Evaluation of thier Antiemetic Effect.

Authors:  Hala Bakr El-Nassan; Aliaa Nabil ElMeshad; Walaa Wadie; Rabab H Sayed
Journal:  Pharm Res       Date:  2018-05-29       Impact factor: 4.200

3.  Responsive organogels formed by supramolecular self assembly of PEG-block-allyl-functionalized racemic polypeptides into β-sheet-driven polymeric ribbons.

Authors:  Jiong Zou; Fuwu Zhang; Yingchao Chen; Jeffery E Raymond; Shiyi Zhang; Jingwei Fan; Jiahua Zhu; Ang Li; Kellie Seetho; Xun He; Darrin J Pochan; Karen L Wooley
Journal:  Soft Matter       Date:  2013-07-10       Impact factor: 3.679

Review 4.  Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review.

Authors:  Rajiv Kumar; Om Prakash Katare
Journal:  AAPS PharmSciTech       Date:  2005-10-06       Impact factor: 3.246

5.  Unnatural Amino Acid: 4-Aminopyrazolonyl Amino Acid Comprising Tri-Peptides Forms Organogel With Co-Solvent (EtOAc:Hexane).

Authors:  Amarnath Bollu; Prajnanandan Giri; Nihar Ranjan Dalabehera; Asmita Rani Asmi; Nagendra K Sharma
Journal:  Front Chem       Date:  2022-05-05       Impact factor: 5.545

6.  Olive oil based novel thermo-reversible emulsion hydrogels for controlled delivery applications.

Authors:  Vinay K Singh; Sowmya Ramesh; Kunal Pal; Arfat Anis; Dillip K Pradhan; Krishna Pramanik
Journal:  J Mater Sci Mater Med       Date:  2013-12-11       Impact factor: 3.896

7.  Pharmaceutical organogels prepared from aromatic amino acid derivatives.

Authors:  Guillaume Bastiat; Jean-Christophe Leroux
Journal:  J Mater Chem       Date:  2009-04-28

8.  In situ-forming oleogel implant for rivastigmine delivery.

Authors:  Anda Vintiloiu; Michel Lafleur; Guillaume Bastiat; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2007-08-12       Impact factor: 4.200

9.  Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.

Authors:  Tarek A Ahmed; Hany M Ibrahim; Ahmed M Samy; Alaa Kaseem; Mohammad T H Nutan; Muhammad Delwar Hussain
Journal:  AAPS PharmSciTech       Date:  2014-03-20       Impact factor: 3.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.